Replies to post #467 on NRX Pharmaceuticals Inc (NRXP)

[PennyWorld]

iddrisw... I read it the same way. He was trying to explain the FDA decision delay on EUA. Possibly, he did not mean to leave that impression. Possibly the FDA can be given a sneak preview of the study results before it's officially complete, or the moment it is unblinded.

If you have his contact number, maybe ask him to clarify it. I do not have his contact information.

Thanks

[TurdBlossom]

About 2 months ago I brought up the issue of a possible conflict between granting EUA prior to completing or at least completing enrollment for the Activ3b trial. Y@h00! MB pumpers did not appreciate the question and had it deleted after a few ad hominem attacks.
I do not understand why, if EUA were to granted, anyone would enroll in a trial with a chance to be in the trial arm which did not receive Aviptadil. I can see the government wanting the Activ3b trial completed because 1) they have already sunk a bunch of money into the trial 2) they need to have data to support replacing Rem as SOC, and 3) Public perception of FDA doing sufficient DD by approving EUA based on a ‘large’ study. The general public has no clue what p-values are but they are used to hearing about BP trials with 10,000 participants. My opinion and I hope I am completely wrong with EUA ‘next week’ so that I can sell the warrants to put into other investments but I am here for the long run regardless.